Skip to Content

NanoLogix Inc NNLX

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NNLX is trading at a 65% discount.
Price
$0.00
Fair Value
$6.78
Uncertainty
Extreme
1-Star Price
$9.79
5-Star Price
Economic Moat
Ncwkm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NNLX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.05
Market Cap
$162.89
Volume/Avg
2,083 / 9,437

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NanoLogix Inc is a biotechnology company specializing in live cell, rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical, national defense, and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrials, veterinary and environmental testing.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees

Valuation

Metric
NNLX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NNLX
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NNLX
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRMtncxswrFcvj$557.8 Bil
VRTX
Vertex Pharmaceuticals IncJwfxdfwbxYxkrng$103.3 Bil
REGN
Regeneron Pharmaceuticals IncKyldqbjmxMkppc$98.8 Bil
MRNA
Moderna IncYwfvdtdWjmc$38.8 Bil
ARGX
argenx SE ADRVqccjklbwYddy$21.3 Bil
BNTX
BioNTech SE ADRQgftvvdCwxt$20.8 Bil
ALNY
Alnylam Pharmaceuticals IncPkvptpfftKmvhyk$18.4 Bil
BMRN
Biomarin Pharmaceutical IncPckhhxdtWfzfjmj$17.0 Bil
RPRX
Royalty Pharma PLC Class AKpcxhkljdZyhkhn$12.4 Bil
INCY
Incyte CorpQslvydtpXjqhrwb$11.9 Bil

Sponsor Center